A revised draft House bill on tracking drug products through the supply chain adds authority for FDA to require tracing at the package level – but pushes out proposed rules for that step for nearly a decade and a half.
In contrast, a pending Senate proposal would require tracing at the package, or unit, level to be well under way by then, setting a deadline of 10 years after enactment of a track-and-trace law